Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Oct 14, 2009; 15(38): 4844-4848
Published online Oct 14, 2009. doi: 10.3748/wjg.15.4844
Published online Oct 14, 2009. doi: 10.3748/wjg.15.4844
Variables | Relative risk (95% CI) | P-value |
Univariate | ||
Gender | 0.674 (0.308-1.474) | 0.320 |
Age | 0.689 (0.423-1.123) | 0.133 |
Tumor size | 1.752 (1.028-2.986) | 0.037a |
Histological differentiation | 1.728 (0.855-3.495) | 0.083 |
Liver cirrhosis | 1.689 (1.047-2.725) | 0.030a |
HBsAg | 1.488 (0.680-3.252) | 0.316 |
Serum AFP | 1.990 (1.105-3.585) | 0.019a |
Metastasis | 1.368 (0.733-2.554) | 0.323 |
NRSN2 | 0.470 (0.265-0.836) | 0.008a |
Multivariate | ||
Liver cirrhosis | 1.739 (1.076-2.808) | 0.024a |
Serum AFP | 1.957 (1.086-3.528) | 0.025a |
NRSN2 | 0.481 (0.270-0.854) | 0.013a |
-
Citation: Ma HQ, Liang XT, Zhao JJ, Wang H, Sun JC, Chen YB, Pan K, Xia JC. Decreased expression of
Neurensin-2 correlates with poor prognosis in hepatocellular carcinoma. World J Gastroenterol 2009; 15(38): 4844-4848 - URL: https://www.wjgnet.com/1007-9327/full/v15/i38/4844.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.4844